NASDAQ:PAHC

Phibro Animal Health (PAHC) Stock Forecast, Price & News

$12.65

-0.12 (-0.94%)

(As of 01:03 PM ET)

Compare

Today's Range: $12.51
▼
$12.79
50-Day Range: $12.43
▼
$15.29
52-Week Range: $11.75
▼
$16.52

Volume: 26,739 shs
Average Volume: 98,814 shs
Market Capitalization: $512.33 million

P/E Ratio: 15.62
Dividend Yield: 3.79%
Price Target: $18.67

Phibro Animal Health MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.67 Rating Score
Upside/Downside: 47.8% Upside
$18.67 Price Target
Short Interest: Bearish
2.10% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -3.93
Upright™ Environmental Score
News Sentiment: 0.80
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 9.24%
From $1.19 to $1.30 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.80 out of 5 stars

Medical Sector

72nd out of 969 stocks

Pharmaceutical Preparations Industry

18th out of 453 stocks

3.3

Analyst's Opinion

Consensus Rating
Phibro Animal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $18.67, Phibro Animal Health has a forecasted upside of 47.8% from its current price of $12.63.
Amount of Analyst Coverage
Phibro Animal Health has only been the subject of 2 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
2.10% of the float of Phibro Animal Health has been sold short.
Short Interest Ratio / Days to Cover
Phibro Animal Health has a short interest ratio ("days to cover") of 4.3.
Change versus previous month
Short interest in Phibro Animal Health has recently increased by 9.20%, indicating that investor sentiment is decreasing significantly.

3.3

Dividend Strength

Dividend Leadership
Phibro Animal Health is a leading dividend payer. It pays a dividend yield of 3.76%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Phibro Animal Health does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Phibro Animal Health is 59.26%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Phibro Animal Health will have a dividend payout ratio of 36.92% next year. This indicates that Phibro Animal Health will be able to sustain or increase its dividend.

1.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Phibro Animal Health has received a -45.84% net impact score from Upright. The largest negative impact of Phibro Animal Health in category "GHG emissions" seems to be driven mostly by its "Animal feed supplements", "Cattle vaccines", and "Poultry vaccines" products. See details.
Environmental Sustainability
The Environmental Impact score for Phibro Animal Health is -3.93.

3.2

News and Social Media Coverage

News Sentiment
Phibro Animal Health has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Phibro Animal Health this week, compared to 1 article on an average week.
MarketBeat Follows
1 people have added Phibro Animal Health to their MarketBeat watchlist in the last 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Phibro Animal Health insiders have not sold or bought any company stock.
Percentage Held by Insiders
50.06% of the stock of Phibro Animal Health is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
99.34% of the stock of Phibro Animal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Phibro Animal Health are expected to grow by 9.24% in the coming year, from $1.19 to $1.30 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Phibro Animal Health is 15.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.33.
Price to Earnings Ratio vs. Sector
The P/E ratio of Phibro Animal Health is 15.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 102.00.
Price to Earnings Growth Ratio
Phibro Animal Health has a PEG Ratio of 2.95. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Phibro Animal Health has a P/B Ratio of 1.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

PAHC Price History

30 days | 90 days | 365 days | Advanced Chart

PAHC Stock News Headlines

September 29, 2023 | finance.yahoo.com

Why Is Phibro (PAHC) Down 10.9% Since Last Earnings Report?

September 25, 2023 | finance.yahoo.com

Should You Be Worried About Phibro Animal Health Corporation's (NASDAQ:PAHC) 12% Return On Equity?

October 2, 2023 | PressReach (Ad)

Nuclear Revival Creates Opportunities for Uranium

Uranium companies set to benefit from increased demand for clean energy.

September 22, 2023 | americanbankingnews.com

Phibro Animal Health Co. Forecasted to Earn FY2024 Earnings of $1.21 Per Share (NASDAQ:PAHC)

September 7, 2023 | finance.yahoo.com

Why Shares of Phibro Animal Health Are Dropping This Week

September 6, 2023 | finance.yahoo.com

TerraCycle Appoints New Chief Financial Officer to Global Leadership Team

September 1, 2023 | markets.businessinsider.com

Where Phibro Animal Health Stands With Analysts

September 1, 2023 | finance.yahoo.com

Phibro (PAHC) Q4 Earnings Miss Estimates, Gross Margin Falls

October 2, 2023 | Behind the Markets (Ad)

Laser breakthrough could send stock soaring 2,467%

Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...

September 1, 2023 | finance.yahoo.com

Phibro Animal Health Corporation (NASDAQ:PAHC) Q4 2023 Earnings Call Transcript

August 31, 2023 | finance.yahoo.com

Q4 2023 Phibro Animal Health Corp Earnings Call

August 30, 2023 | msn.com

Roth MKM Reiterates Phibro Animal Health - (PAHC) Buy Recommendation

August 29, 2023 | benzinga.com

Earnings Outlook For Phibro Animal Health

August 29, 2023 | markets.businessinsider.com

What Wall Street expects from Phibro Animal Health A's earnings

August 23, 2023 | finance.yahoo.com

Phibro Animal Health (PAHC) Earnings Expected to Grow: Should You Buy?

August 17, 2023 | finance.yahoo.com

Phibro's (PAHC) Sales Hurt by Rising Costs, FX Headwind

July 31, 2023 | finance.yahoo.com

Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2023 Results

July 28, 2023 | msn.com

Morgan Stanley Reiterates Phibro Animal Health - (PAHC) Equal-Weight Recommendation

July 23, 2023 | finance.yahoo.com

Investors in Phibro Animal Health (NASDAQ:PAHC) have unfortunately lost 65% over the last five years

May 25, 2023 | finance.yahoo.com

Phibro Animal Health Corporation (NASDAQ:PAHC) Shares Could Be 29% Above Their Intrinsic Value Estimate

May 12, 2023 | seekingalpha.com

Phibro Animal Health Corporation 2023 Q3 - Results - Earnings Call Presentation

May 8, 2023 | finance.yahoo.com

Phibro Issues Second Environmental, Social and Governance Report

May 5, 2023 | msn.com

Morgan Stanley Maintains Phibro Animal Health - (PAHC) Equal-Weight Recommendation

May 5, 2023 | finance.yahoo.com

Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12

May 4, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Intra-Cellular Therapies (ITCI), Phibro Animal Health (PAHC) and Moleculin Biotech (MBRX)

May 4, 2023 | finance.yahoo.com

Phibro Animal Health (PAHC) Q3 Earnings Lag Estimates

May 3, 2023 | msn.com

Recap: Phibro Animal Health Q3 Earnings

See More Headlines

Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Company Calendar

Last Earnings: 8/31/2023
Ex-Dividend for 9/27 Dividend: 9/05/2023
Dividend Payable: 9/27/2023
Today: 10/02/2023
Next Earnings (Estimated): 11/08/2023
Fiscal Year End: 6/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:PAHC
CUSIP: N/A
CIK: 1069899
Web: www.pahc.com
Phone: (201) 329-7300
Fax: 201-329-7399
Employees: 1,920
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $18.67
High Stock Price Forecast: $21.00
Low Stock Price Forecast: $17.00
Forecasted Upside/Downside: +46.2%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.67
Research Coverage: 3 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.81
Trailing P/E Ratio: 15.77
Forward P/E Ratio: 10.73
P/E Growth: 2.95
Net Income: $32.61 million
Net Margins: 3.33%
Pretax Margin: 5.53%
Return on Equity: 18.05%
Return on Assets: 5.09%

Debt

Debt-to-Equity Ratio: 1.60
Current Ratio: 3.33
Quick Ratio: 1.75

Sales & Book Value

Annual Sales: $977.90 million
Price / Sales: 0.53
Cash Flow: $2.07 per share
Price / Cash Flow: 6.18
Book Value: $6.97 per share
Price / Book: 1.83

Miscellaneous

Outstanding Shares: 40,500,000
Free Float: 20,227,000
Market Cap: $517.19 million
Optionable: Optionable
Beta: 0.63

10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Jack Clifford Bendheim (Age 76)
Chairman, Pres & CEO
Comp: $2.9M

Mr. Damian Finio (Age 53)
Chief Financial Officer
Comp: $567.46k

Mr. Larry L. Miller (Age 59)
Chief Operating Officer
Comp: $774.91k

Mr. Daniel M. Bendheim (Age 51)
Exec. VP of Corp. Strategy & Director
Comp: $548.18k

Mr. Rob Aukerman (Age 65)
Pres of North America Region
Comp: $619.27k

Ms. Judith A. Weinstein (Age 54)
Sr. VP, Gen. Counsel & Corp. Sec.

Ms. Lisa A. Escudero (Age 61)
Sr. VP of HR

Mr. Jonathan Bendheim (Age 47)
Pres of MACIE Region, GM of Israel Operations & Director

Mr. Ramon Fuenmayor
Pres South America Region

Mr. Samson Li (Age 51)
Pres of Asia Pacific Region

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

PAHC Stock - Frequently Asked Questions

Should I buy or sell Phibro Animal Health stock right now?: 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" PAHC shares.
View PAHC analyst ratings or view top-rated stocks.
What is Phibro Animal Health's stock price forecast for 2023?: 3 Wall Street research analysts have issued twelve-month target prices for Phibro Animal Health's stock. Their PAHC share price forecasts range from $17.00 to $21.00. On average, they anticipate the company's stock price to reach $18.67 in the next year. This suggests a possible upside of 46.2% from the stock's current price.
View analysts price targets for PAHC or view top-rated stocks among Wall Street analysts.
How have PAHC shares performed in 2023?: Phibro Animal Health's stock was trading at $13.41 on January 1st, 2023. Since then, PAHC shares have decreased by 4.8% and is now trading at $12.77.
View the best growth stocks for 2023 here.
When is Phibro Animal Health's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our PAHC earnings forecast.
How were Phibro Animal Health's earnings last quarter?: Phibro Animal Health Co. (NASDAQ:PAHC) posted its quarterly earnings results on Thursday, August, 31st. The company reported $0.38 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.40 by $0.02. The company earned $255 million during the quarter, compared to analyst estimates of $256.68 million. Phibro Animal Health had a net margin of 3.33% and a trailing twelve-month return on equity of 18.05%. During the same quarter in the prior year, the firm posted $0.36 earnings per share.
How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?: Phibro Animal Health declared a quarterly dividend on Tuesday, July 25th. Shareholders of record on Wednesday, September 6th will be given a dividend of $0.12 per share on Wednesday, September 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.76%. The ex-dividend date is Tuesday, September 5th.
Read our dividend analysis for PAHC.
What ETFs hold Phibro Animal Health's stock?: ETFs with the largest weight of Phibro Animal Health (NASDAQ:PAHC) stock in their portfolio include Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD).iShares U.S. Pharmaceuticals ETF (IHE).
Is Phibro Animal Health a good dividend stock?: Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.76%. The dividend payout ratio is 59.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PAHC will have a dividend payout ratio of 36.92% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

What guidance has Phibro Animal Health issued on next quarter's earnings?: Phibro Animal Health updated its FY24 earnings guidance on Wednesday, August, 30th. The company provided earnings per share guidance of $1.12-1.27 for the period, compared to the consensus EPS estimate of $1.29. The company issued revenue guidance of $1.00-1.05 billion, compared to the consensus revenue estimate of $1.01 billion.
What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?: 4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Phibro Animal Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).
What is Phibro Animal Health's stock symbol?: Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."
How do I buy shares of Phibro Animal Health?: Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Phibro Animal Health's stock price today?: One share of PAHC stock can currently be purchased for approximately $12.77.
How much money does Phibro Animal Health make?: Phibro Animal Health (NASDAQ:PAHC) has a market capitalization of $517.19 million and generates $977.90 million in revenue each year. The company earns $32.61 million in net income (profit) each year or $0.81 on an earnings per share basis.
How many employees does Phibro Animal Health have?: The company employs 1,920 workers across the globe.
How can I contact Phibro Animal Health?: Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The official website for the company is www.pahc.com. The company can be reached via phone at (201) 329-7300, via email at investor.relations@pahc.com, or via fax at 201-329-7399.

This page (NASDAQ:PAHC) was last updated on 10/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial